Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Minerva Gastroenterologica e Dietologica 2012 December;58(4) > Minerva Gastroenterologica e Dietologica 2012 December;58(4):331-45

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

A Journal on Gastroenterology, Nutrition and Dietetics


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

  PANCREATIC DISEASES: A CLOSER LOOK


Minerva Gastroenterologica e Dietologica 2012 December;58(4):331-45

Copyright © 2012 EDIZIONI MINERVA MEDICA

language: English

Diabetes and pancreatic cancer

Muniraj T. 1, Chari S. T. 2

1 Yale University School of Medicine, New Haven, CT USA; 2 Mayo Clinic College of Medicine, Rochester MN USA


PDF  


The relationship between diabetes and pancreatic cancer is complex. Diabetes or impaired glucose tolerance is present in more than 2/3rd of pancreatic cancer patients. Epidemiological studies have consistently shown a modest increase in the risk of pancreatic cancer in type 2 diabetes, with an inverse relationship to duration of disease. Additionally, recent studies suggest that anti-diabetic medications may modulate the risk of pancreatic cancer in type 2 diabetes. Subjects >50 years of age with new onset diabetes are at higher risk of having pancreatic cancer. However, to screen new-onset diabetes for pancreatic cancer, additional markers are needed that can distinguish pancreatic cancer-associated diabetes from type 2 diabetes.

top of page

Publication History

Cite this article as

Corresponding author e-mail

chari.suresh@mayo.edu